/
PFSA
$0.90-$0.05 (-5.34%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$511.5K
1M shares
52-week range
$0.81 – $1,297.50
0% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-3786.60
Profusa, Inc. Common Stock
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
www.profusa.com- IPO / List date
- Jul 14, 2025
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds PFSA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PFSA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-08-17 | 1-for-4reverse |
| 2026-07-07 | 1-for-25reverse |
| 2026-02-09 | 1-for-75reverse |
Recent trades on TradeandTell
No one on the platform has traded PFSA yet.
